Current and historical daily PE Ratio for Edwards Lifesciences Corp (
MIL:1EW
) from 2023 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Edwards Lifesciences stock (MIL:1EW) PE ratio as of Jun 20 2024 is 38.16.
More Details
Edwards Lifesciences Corp (MIL:1EW) PE Ratio (TTM) Chart
Edwards Lifesciences Corp (MIL:1EW) PE Ratio (TTM) Historical Data
View and export this data going back to 2023. Start your Free Trial
Total 135
- 1
- 2
Edwards Lifesciences PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-21 | 37.3 | 2024-04-18 | 39.6 |
2024-06-19 | 37.3 | 2024-04-17 | 39.6 |
2024-06-18 | 37.3 | 2024-04-16 | 39.6 |
2024-06-17 | 37.3 | 2024-04-15 | 39.6 |
2024-06-14 | 37.3 | 2024-04-12 | 39.6 |
2024-06-13 | 37.3 | 2024-04-11 | 40.1 |
2024-06-12 | 37.3 | 2024-04-10 | 40.1 |
2024-06-11 | 37.3 | 2024-04-09 | 40.1 |
2024-06-10 | 37.3 | 2024-04-08 | 40.1 |
2024-06-07 | 37.3 | 2024-04-05 | 40.1 |
2024-06-06 | 37.3 | 2024-04-04 | 40.1 |
2024-06-05 | 37.3 | 2024-04-03 | 40.1 |
2024-06-04 | 37.3 | 2024-04-02 | 40.1 |
2024-06-03 | 37.4 | 2024-04-01 | 40.1 |
2024-05-31 | 37.3 | 2024-03-29 | 40.1 |
2024-05-30 | 37.3 | 2024-03-28 | 40.1 |
2024-05-29 | 37.3 | 2024-03-27 | 40.3 |
2024-05-28 | 37.3 | 2024-03-26 | 40.3 |
2024-05-27 | 39.6 | 2024-03-25 | 40.3 |
2024-05-24 | 39.6 | 2024-03-22 | 40.5 |
2024-05-23 | 39.6 | 2024-03-21 | 40.8 |
2024-05-22 | 39.6 | 2024-03-20 | 40.1 |
2024-05-21 | 39.6 | 2024-03-19 | 40.1 |
2024-05-20 | 39.6 | 2024-03-18 | 40.1 |
2024-05-17 | 39.6 | 2024-03-15 | 36.9 |
2024-05-16 | 39.6 | 2024-03-14 | 36.9 |
2024-05-15 | 39.6 | 2024-03-13 | 36.9 |
2024-05-14 | 39.6 | 2024-03-12 | 36.9 |
2024-05-13 | 39.6 | 2024-03-11 | 36.9 |
2024-05-10 | 39.6 | 2024-03-08 | 36.9 |
2024-05-09 | 39.6 | 2024-03-07 | 36.9 |
2024-05-08 | 39.6 | 2024-03-06 | 36.9 |
2024-05-07 | 39.6 | 2024-03-05 | 36.9 |
2024-05-06 | 39.6 | 2024-03-04 | 36.9 |
2024-05-03 | 39.6 | 2024-03-01 | 36.9 |
2024-05-02 | 39.6 | 2024-02-29 | 36.9 |
2024-05-01 | 39.6 | 2024-02-28 | 37.7 |
2024-04-30 | 39.6 | 2024-02-27 | 37.7 |
2024-04-29 | 39.6 | 2024-02-26 | 37.7 |
2024-04-26 | 39.6 | 2024-02-23 | 37.7 |
2024-04-25 | 39.6 | 2024-02-22 | 37.7 |
2024-04-24 | 39.6 | 2024-02-21 | 37.7 |
2024-04-23 | 39.6 | 2024-02-20 | 37.7 |
2024-04-22 | 39.6 | 2024-02-19 | 37.7 |
2024-04-19 | 39.6 | 2024-02-16 | 37.7 |
Edwards Lifesciences Corp (MIL:1EW) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Edwards Lifesciences Corp
NAICS : 339113
SIC : 3842
ISIN : US28176E1082
Description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.